Loading organizations...
Loading organizations...
Discovery and development of therapeutics for oncology and infections.
Nereus Pharmaceuticals has raised $65.0M across 2 funding rounds.
Nereus Pharmaceuticals has raised $65.0M in total across 2 funding rounds.
Nereus Pharmaceuticals has raised $65.0M in total across 2 funding rounds.
Nereus Pharmaceuticals's investors include HBM Healthcare Investments, Advent International, Alta Partners, Astellas Venture Management, Forward Ventures, Gimv, Pacific Venture Group, Roche, BankInvest Biomedical Venture, Boston Life Science Venture Corporation, Eminent II Venture Capital, InterWest Partners.
Nereus Pharmaceuticals has raised $65.0M across 2 funding rounds. Most recently, it raised $20.0M Other Equity in June 2010.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 23, 2010 | $20.0M Other Equity | HBM Healthcare Investments | Advent International, Alta Partners, Astellas Venture Management, Forward Ventures, Gimv, Pacific Venture Group, Roche |
| Aug 9, 2007 | $45.0M Series D | BankInvest Biomedical Venture | Advent International, Alta Partners, Astellas Venture Management, Boston Life Science Venture Corporation, Eminent II Venture Capital, Forward Ventures, Gimv, HBM Healthcare Investments, InterWest Partners, Pacific Venture Group, Roche, Taiwan Global Biofund |